Deya Mohammad Obaidat, MBBS

Deya Obaidat practices at Community Health Network in Indianapolis, Indiana.

Deya Obaidat's NPI, 1215460316, was assigned on April 5, 2017. Deya Obaidat holds Indiana license 01087384A.

Deya Obaidat's primary practice is Community Health Network, at 7240 Shadeland Sta, Indianapolis, IN 46256 in Marion County. The practice phone is (317) 355-5555.

Deya Obaidat's primary practice is Community Health Network in Indianapolis, Indiana. Deya Obaidat is also affiliated with Community Hospital South. The medical group on file is Community Physician Network. Dmand AI also links Deya Obaidat to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Deya Obaidat practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Deya Obaidat's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Deya Obaidat is licensed in Indiana.

CMS data shows 1,068 Medicare services from Deya Obaidat across 5 procedure codes in 2024, for 333 Medicare patients. Medicare paid $44,180 for them.

CMS counts 333 Medicare patients who saw Deya Obaidat in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have arthritis, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Deya Obaidat's median patient age at 67, with 71% women.

In 2024, Deya Obaidat wrote 3,604 Medicare Part D claims for 655 patients. 72% of them were for generic drugs. CMS names the drug for 3,445 of them, across 46 drugs with 11 or more claims each, at $6,375,941 in total drug cost. In 2023, CMS named 1,648 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Deya Obaidat for performance year 2024, reported as part of a group. Deya Obaidat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Deya Obaidat as offering telehealth.

Dmand AI links 2 papers to Deya Obaidat in 2023. 2023 was the busiest year, with 2. Deya Obaidat's most frequent co-authors are Salman Ayub, MD and Marie-Claire Maroun, MD.

CMS Open Payments shows 192 general payments to Deya Obaidat from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $1,468.